Cel Sci CORP (CVM) SEC Filings — 2024

Filings

• CEL-SCI CORP Files 8-K: Material Agreement & Other Events — 8-K · Dec 31, 2024
• CEL-SCI CORP: Director Changes & Officer Compensation Updates — 8-K · Nov 15, 2024
• CEL-SCI Corp raises $2.45M via direct offering — 8-K · Nov 13, 2024
• CEL-SCI CORP Files 8-K — 8-K · Sep 17, 2024
• CEL SCI CORP 10-Q: Assets $54.26M, Liabilities $47.42M — 10-Q · Aug 14, 2024
• CEL-SCI Corp Files 8-K: Material Agreement & Other Events — 8-K · Jul 29, 2024
• CEL-SCI Corp Files 8-K: Reporting Other Events & Exhibits — 8-K · Jul 26, 2024
• CEL-SCI Receives FDA Complete Response Letter for Multikine — 8-K · Jun 20, 2024
• CEL SCI CORP Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 15, 2024
• CEL-SCI Corp Reports Director/Officer Changes — 8-K · Apr 23, 2024
• CEL-SCI Corp Files 8-K on Shareholder Vote Matters — 8-K · Apr 19, 2024
• CEL-SCI CORP Files DEFA14A Proxy Materials — DEFA14A · Mar 7, 2024
• CEL SCI CORP Files 10-Q for Period Ending December 31, 2023 — 10-Q · Feb 14, 2024
• CEL-SCI Enters Material Definitive Agreement on Feb 8 — 8-K · Feb 13, 2024